Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosslyn Data Regulatory News (RDT)

Share Price Information for Rosslyn Data (RDT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
RDT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

31 Jan 2022 07:00

RNS Number : 0496A
Rosslyn Data Technologies PLC
31 January 2022
 

Rosslyn Data Technologies plc

(the "Company", "RDT" or the "Group")

 

Interim results for the six months ended 31 October 2021

 

Rosslyn (AIM:RDT), the provider of a leading cloud based enterprise data analytics platform announces its interim results for the six months ended 31 October 2021.

 

Highlights

 

· Significant Investment into core Rapid product, which includes: a transformation of the UI/UX interface, a foundation architecture built to deliver advanced intelligent automation and machine learning; and an enhancement to the product's data mining capabilities.

· Group revenues of £3.1 million (H1 2021: £3.6 million) and gross profit margin of 81.7% (H1 2021 82.2%)

· Administrative expenses increased to £3.91 million (H1 2021: £3.14 million) as a result of investment into product Marketing

· Operating EBITDA loss was £1.38 million (H1 2021: £146,000 loss)

· Annual Recurring Revenue ("ARR") of £5.3 million (H1 FY2021: £6.2 million)

· We have won three major new deals during this period, including a large 7-figure contract with one of the largest pharmaceutical companies in the world.

 

 

Paul Watts, CEO commented, "Much has been accomplished during the first half of the year to set the Group on a growth trajectory. There was much change in the business set against a complex external operating environment as a result of Covid. However, I believe the Group is now on the right path; we have an ambitious new leadership team in place with a desire and focus to drive growth. The development upgrades to our core RAPid product, together with a brand refresh, will, I believe, fully transform our business and enable us to adopt a new approach to drive scalability, broaden the number of potential users. As we now enter the next phase of our turnaround project, I believe the market opportunity for Rosslyn has never been greater and am excited about what the future holds."

 

 

Rosslyn Data Technologies plc

Paul Watts, Chief Executive Officer

+44(0) 7555 144983+44(0)20 3285 8008

 

James Appleby, Chairman

+44 (0) 7940 560624

 

 

 

Cenkos Securities,Nominated Adviser, Broker

Stephen Keys/Camilla Hume/Giles Balleny

 

+44(0)20 7397 8900

 

Chief Executive's Review

The first half year has been an exciting one at Rosslyn where we have embarked on and completed the first phase of a major restructure of our business strategy. On taking over as CEO in April 2021, I instigated a deep dive audit of the core assets within the business. This included not only looking at the products, but also our execution capability across R&D, marketing, sales, and customer support.

The audit project was completed by the middle of the year, with a number of key observations;

· The Company's core RAPid product still has a strong value proposition within the spend analytics marketplace but was in need of some major modernisation; primarily to transform the user experience, but also to extend the core value of this data deeper into where spend and supplier information management overlap. As such we have invested heavily in developing the next generation of the RAPid product to address these needs which is expected to be launched before the end of March 2022;

· The R&D function has established a product strategy group within the company to better capture requirements and focus on next generation intelligent automation technology,

As much as the feedback captured from customers was positive, it was felt essential that we form a Customer Advisory Board, to marry our strategic product roadmap with the customer's experiences and objectives, which met for the first time in January 2022.

As a result of the operational overview conducted, we have refreshed the Group's Operational Leadership Team, which now consists of 80% new employees all coming from within the B2B SaaS enterprise software space, with a proven track record for executing successful turnaround projects. This team has now been in place for 4-months and I am extremely pleased with how the team is working together.

Importantly we have now have the leadership in place and a focussed strategy upon which to execute which includes, amongst other things;

· To return the business to focus on one core product, that has the highest growth potential, our spend analytics platform, RAPid. This is the Rosslyn spend analytics platform.

· To re-brand Rosslyn, in early 2022, in tandem with the launch of the new version of the software, to present ourselves as a modern focused visionary thought-leader in our market place, underpinned with the most industrial strength solution.

As previously stated the Integritie and Langdon Systems acquisitions, whilst performing well since they became part of the Group, have limited crossover in terms of customer base or strategic rationale. As a result, we are continuing to evaluate how to best capitalize on the Group's core business and deliver the best value to shareholders, which may include the divestment of these non-core elements of the Group.

With a clear strategy now in place for the second half of the year, the focus has shifted to execution of this strategy in order to drive growth and deliver shareholder value. Our objectives in the second half of the year will be:

· To establish core KPI's by which to drive and measure the success of the business in line with industry best practice for B2B SaaS enterprise software;

· To empower the new leadership team with an entrepreneurial operating model to drive their line of business in a fully collaborative environment;

· To put the customer experience at the centre of our business, with a laser focus on ensuring they extract maximum value from our solution;

· To release the new version of Rosslyn with strong customer, partner and analyst endorsement;

· To launch the new re-branded Rosslyn into the marketplace, with voice of customer, and product strategy being at the centre of our core values; and

· To modernise the go-to-market model to incorporate a strong focus on partners. This comes out the back of significant wins with both new and established partners in the first half.

Operational Update

At this time of restructuring, and a change in corporate strategy towards being a single product company we have continued to focus on executing at an operational level.

Our primary focus has been around securing a stronger alignment between our product strategy and customer success execution. We have employed new leadership for both parts of this business. We have also formed our first Customer Advisory Board and produced our first product roadmap with full customer validation. Combining this customer input with the work completed during our strategic audits in mid-year, as well as recent positive reviews from key analysts like SpendMatters (Rosslyn was nominated as a Top-50 vendors in procurement to watch in 2022), give us confidence for the future.

 

We have won three major new deals during this period, including a large 7-figure contract with one of the largest pharmaceutical companies in the world. There have also been key wins with our partners in the USA and the UK. We will look to expand our partner strategy in 2022, as there is a strong trend across procurement transformation towards architecting best of breed technology.

Our development team is now in Beta testing stage with customers for the highly anticipated Rosslyn-10 platform. This new version will provide the foundation for accelerated enhancements through 2022, as we move our core technology to one that can truly leverage agile development best practice and be deployed in a true SaaS way. This first release will be a complete transformation of the user interface and is focused on democratising complex data technology to non-IT procurement professionals.

Outlook

Rosslyn now finds itself with a new leadership team of experienced professionals from the software industry, who are charged with our next phase of execution. The combination of bringing together the customer and product as the central nervous system of our execution, and the relaunching of a new brand into the market we expect to give us a springboard into 2022 and beyond. We look to the future with increasing confidence.

 

 

 

 

 

 

 

Consolidated statement of comprehensive income

For the six months ended 31 October 2021

 

 

Notes

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Revenue

3

3,094

3,573

7,417

Cost of sales

 

(565)

(636)

(1,316)

Gross profit

 

2,529

2,937

6,101

Other operating income

4

-

54

89

Administrative expenses

 

(3,905)

(3,137)

(7,248)

Depreciation and amortisation

 

(566)

(567)

(1,106)

Share based payment

 

(61)

(120)

(204)

Operating loss

 

(2,003)

(833)

(2,368)

Finance income

 

3

17

34

Finance costs

 

(50)

(67)

(124)

Loss before income tax

 

(2,050)

(883)

(2,458)

Income tax credit

 

156

171

486

Loss for the period

 

(1,894)

(712)

(1,972)

Other comprehensive loss

 

-

-

(2)

Total comprehensive income

 

(1,894)

(712)

(1,974)

 

 

 

 

 

 

Loss per share

 

 

 

 

Basic and diluted loss per share: ordinary shareholders (pence)

5

(0.56)

(0.21)

(0.60)

 

 

 

 

Consolidated balance sheet

As at 31 October 2021

 

 

31 October 2021

Unaudited

£'000

31 October

2020

Unaudited

£'000

30 April

2021

Audited

£'000

ASSETS

 

 

 

Non-current assets

 

 

 

Intangible assets

512

1,491

994

Property, plant and equipment

52

17

55

Right-of-use assets

368

99

73

 

932

1,607

1,122

Current assets

 

 

 

Trade and other receivables

1,817

2,548

2,354

Corporation tax receivable

429

332

309

Cash and cash equivalents

4,834

7,227

6,681

 

7,080

10,107

9,344

Total assets

8,012

11,714

10,466

LIABILITIES

 

 

 

Current liabilities

 

 

 

Trade and other payables

(4,281)

(4,331)

(4,489)

Financial liabilities - borrowings

(726)

(388)

(890)

 

(5,007)

(4,719)

(5,379)

Non-current liabilities

 

 

 

Trade and other payables

(173)

(414)

(386)

Deferred tax

(36)

(109)

(73)

Financial liabilities - borrowings

-

(666)

-

 

(209)

(1,189)

(459)

Total liabilities

(5,216)

(5,908)

(5,838)

Net assets/(liabilities)

2,796

5,806

(4,628)

 

Equity

 

 

 

Called up share capital

1,699

1,699

1,699

Share premium

18,923

18,923

18,923

Share-based payment reserve

580

590

657

Accumulated loss

(23,416)

(20,419)

(21,662)

Translation reserve

(123)

(120)

(122)

Merger reserve

5,133

5,133

5,133

Total equity

2,796

5,806

4,628

 

 

Consolidated cash flow statement

For the six months ended 31 October 2021

 

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Cash flows from operating activities

 

 

 

Loss before income tax

(2,050)

(883)

(2,458)

Adjustments for:

 

 

 

- depreciation, amortisation

566

569

1,106

- share-based payments

61

120

204

- finance income

(3)

(17)

(34)

- finance costs

50

67

124

 

(1,376)

(144)

(1,058)

Increase/(decrease) in receivables

537

(509)

(317)

Increase/(decrease) in payables

(776)

431

601

Cash used from operations

(1,615)

(222)

(774)

Finance income

3

17

34

Finance costs

(50)

(67)

(124)

Corporation tax received

-

-

301

Net cash used in operating activities

(1,662)

(272)

(563)

Cash flows from investing activities

 

 

 

Purchase of property, plant and equipment

(21)

(13)

(66)

Net cash used in investing activities

(21)

(13)

(66)

Cash flows from financing activities

 

 

 

Proceeds from share capital issued (net)

-

7,352

7,352

Costs of share issue

-

(472)

(472)

Repayment of bank and other borrowings

(164)

(162)

(364)

Net cash from/(used in) financing activities

(164)

6,718

6,516

Net increase/(decrease) in cash and cash equivalents

(1,847)

6,433

5,887

Cash and cash equivalents at beginning of period

6,681

794

794

Cash and cash equivalents at end of period

4,834

7,227

6,681

 

 

 

Notes to the unaudited interim statements

For the six months ended 31 October 2021

 

1. Basis of preparation

 

This interim report has been prepared in accordance with the accounting policies disclosed in the full statutory accounts for the year ended 30 April 2021.

These policies are in accordance with UK-adopted international accounting standards that are expected to be applicable for the year ending 30 April 2022.

The Group has chosen not to adopt IAS 34 "Interim Financial Statements" in preparing the interim consolidated financial information.

The financial information in this statement relating to the six months ended 31 October 2021 and the six months ended 31 October 2020 has not been audited.

The financial information for the year ended 30 April 2021 does not constitute the full statutory accounts for that period. The annual report and financial statements for the year ended 30 April 2021 has been filed with the Registrar of Companies.

The Independent Auditor's Report on the annual report and financial statements for the year ended 30 April 2021 was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under Section 498(2) or 498(3) of the Companies Act 2006.

The interim report for the period ended 31 October 2021 was approved by the Board of Directors on 28 January 2022.

2. Segmental reporting

 

Management has determined the operating segments based on the operating reports reviewed by the Executive Directors that are used to assess both performance and strategic decisions. Management has identified that the Executive Directors are the Chief Operating Decision-Maker in accordance with the requirements of IFRS 8 Operating segments.

The determination is that the Group operates as a single segment, as no internal reporting is produced either by geography or division. The Group does view performance on the basis of the type of revenue, and the end destination of the client as shown below.

 

Analysis of Revenue by Product

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Annual licence fees

2,675

2,947

5,962

Professional services

419

626

1,455

Total revenue

3,094

3,573

7,417

 

Analysis of Revenue by Country

 

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

United Kingdom

1,989

2,127

4,579

Europe

461

770

1,457

North America

644

676

1,381

Total revenue

3,094

3,573

7,417

Included in Europe is the Netherlands which had revenues of £181,000 in the period ended 30 October 2021 (2020: £475,000).

Included in North America is the USA which had revenues of £559,000 in the period ended 30 October 2021 (2020: £532,000).

 

 

 

 

 

 

Analysis of Future Obligations

 

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Performance obligations to be satisfied in the next year

3,217

2,601

3,865

Performance obligations to be satisfied after 31 October 2022

1,753

3,305

1,951

Total future performance obligations

4,970

5,906

5,816

 

 

 

 

Analysis of Largest Customer

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Annual Licence fees

258

215

360

Professional Services

0

0

95

Total revenue of largest customer

258

215

455

 

There were no significant customers who make up greater than 10% of total revenue in the period.

 

 

3. Operating EBITDA

 

Operating EBITDA is calculated from Operating loss as shown below.

 

 

 

 

Six months

ended

31 October

2021

Unaudited

£'000

Six months

ended

31 October

2020

Unaudited

£'000

Year

ended

30 April

2021

Audited

£'000

Operating loss

(2,003)

(833)

(2,368)

Depreciation and amortisation

566

567

1,106

Share-based payments

61

120

204

Operating EBITDA

(1,376)

(146)

(1,058)

 

 

4. Other operating income

 

Other operating income is amounts received in the form of furlough payments and similar non-repayable grants from government bodies as a result of the coronavirus pandemic.

 

5. Earnings per share

 

Basic earnings per share is calculated by dividing the net loss for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period. Diluted earnings per share is calculated by dividing net loss for the period attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period plus the weighted average number of ordinary shares that would be issued on the conversion into ordinary shares of all potentially dilutive instruments. In the periods ended 31 October 2021, 31 October 2020 and 30 April 2021 there were share options in issue which could potentially have a dilutive impact, but as the Group was loss making they were anti-dilutive for each period and therefore the weighted average number of ordinary shares for the purpose of the basic and dilutive loss per share were the same.

 

Six months

ended

31 October

2021

Unaudited

Six months

ended

31 October

2020

Unaudited

Year

ended

30 April

2021

Audited

Loss for the period attributable to the owners of the parent

£1,894,000

£712,000

£1,972,000

Weighted average number of ordinary shares

339,842,521

339,066,662

328,655,751

 

 

 

Pence

 

Pence

Pence

Basic and diluted loss per share: ordinary shareholders

(0.56)

(0.21)

(0.60)

 

6. Dividends

No interim dividend (2020: nil) will be paid to shareholders.

 

7. Principal risks and uncertainties

The principal risks and uncertainties for this six-month period remain broadly consistent with those set out in the Financial Review section of the financial statements of the Group for the year ended 30 April 2021.

8. Interim report

Copies of the interim report are available to the public on the Group's website at www.rosslyndatatech.com, and from the registered offices of Rosslyn Data Technologies plc at 1000 Lakeside North Harbour, Western Road, Portsmouth, Hampshire, England, PO6 3EN or by email to investors@rosslyndatatech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FLFSDLRITFIF
Date   Source Headline
28th Mar 202412:56 pmRNSHolding(s) in Company
28th Mar 202412:55 pmRNSHolding(s) in Company
6th Mar 202411:49 amRNSHolding(s) in Company
4th Mar 202411:47 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSTrading Update
25th Jan 20246:07 pmRNSReplacement- Interim Results
25th Jan 20247:00 amRNSInterim Results
12th Jan 20249:54 amRNSHolding(s) in Company
12th Jan 20249:52 amRNSHolding(s) in Company
4th Jan 20242:21 pmRNSChange of Registered Address
12th Dec 202311:24 amRNSChange of Nominated Adviser and Broker
8th Dec 20234:42 pmRNSHolding(s) in Company
24th Nov 202312:43 pmRNSHolding(s) in Company
23rd Nov 20231:31 pmRNSResult of AGM
31st Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
27th Oct 20234:15 pmRNSHolding(s) in Company
17th Oct 202312:46 pmRNSHolding(s) in Company
17th Oct 202310:10 amRNSHolding(s) in Company
5th Oct 202310:21 amRNSHolding(s) in Company
2nd Oct 20237:00 amRNSDirectorate Change
26th Sep 202311:08 amRNSHolding(s) in Company
25th Sep 20235:28 pmRNSTR1 - NOTIFICATION OF MAJOR HOLDINGS
25th Sep 20234:51 pmRNSHolding(s) in Company
25th Sep 20233:52 pmRNSHolding(s) in Company
22nd Sep 202311:52 amRNSHolding(s) in Company
21st Sep 202312:43 pmRNSHolding(s) in Company
21st Sep 202312:37 pmRNSHolding(s) in Company
20th Sep 20237:00 amRNSShare Consolidation and Total Voting Rights
19th Sep 20238:07 amRNSDirector Dealings
18th Sep 202312:09 pmRNSResult of General Meeting
5th Sep 20235:02 pmRNSResult of Retail Offer
31st Aug 20237:00 amRNSResult of Placing and Posting of Circular
30th Aug 20234:35 pmRNSRetail Offer
30th Aug 20234:30 pmRNSProposed Placing, Loan Note Issue & Notice of GM
30th May 20237:00 amRNSRosslyn wins two new contracts
11th Apr 20234:40 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSTrading Update
9th Mar 20239:48 amRNSHolding(s) in Company
31st Jan 202311:05 amRNSSecond Price Monitoring Extn
31st Jan 202311:00 amRNSPrice Monitoring Extension
31st Jan 20239:05 amRNSSecond Price Monitoring Extn
31st Jan 20239:00 amRNSPrice Monitoring Extension
30th Jan 20234:40 pmRNSSecond Price Monitoring Extn
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
30th Jan 20237:00 amRNSRosslyn wins new multi-year contract
30th Jan 20237:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.